4 studies found for: "Hepatocellular carcinoma (fibrolamellar variant)"
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
|2||Active, not recruiting||
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
† Study has passed its completion date and status has not been verified in more than two years.